tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market

CNBX Pharmaceuticals (CNBX) Ratios

Compare
122 Followers

CNBX Pharmaceuticals Ratios

CNBX's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, CNBX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Aug 25Aug 24Aug 23Aug 22
Liquidity Ratios
Current Ratio
<0.01 <0.01 0.01 0.09 0.08
Quick Ratio
<0.01 <0.01 0.01 0.09 0.11
Cash Ratio
<0.01 <0.01 0.01 0.05 0.05
Solvency Ratio
-0.15 -0.12 -0.25 -1.41 -1.44
Operating Cash Flow Ratio
-0.07 -0.07 -0.10 -0.04 -0.69
Short-Term Operating Cash Flow Coverage
-0.14 -0.14 -0.19 -0.08 -0.95
Net Current Asset Value
$ -2.57M$ -2.50M$ -2.48M$ -2.29M$ -2.25M
Leverage Ratios
Debt-to-Assets Ratio
111.67 64.94 41.27 2.69 2.17
Debt-to-Equity Ratio
-0.48 -0.48 -0.52 -0.67 -1.08
Debt-to-Capital Ratio
-0.94 -0.92 -1.09 -1.99 13.91
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
>-0.01 >-0.01 -0.01 -0.25 -0.50
Debt Service Coverage Ratio
-0.22 -0.22 -0.46 -2.64 -2.03
Interest Coverage Ratio
-3.16 -6.76 -29.73 -793.02 -2.32K
Debt to Market Cap
89.83 26.42 6.91 9.01 0.42
Interest Debt Per Share
<0.01 0.01 0.04 0.15 1.44
Net Debt to EBITDA
-4.15 -4.32 -2.10 -0.34 -0.47
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%-564.12%
EBIT Margin
0.00%0.00%-519.70%-904.27%-12424.06%
EBITDA Margin
0.00%0.00%-463.58%-864.77%-11759.80%
Operating Profit Margin
0.00%0.00%-448.21%-226.98%-9860.47%
Pretax Profit Margin
0.00%0.00%-534.31%-904.51%-14507.74%
Net Profit Margin
0.00%0.00%-534.31%-904.51%-12427.40%
Continuous Operations Profit Margin
0.00%0.00%-534.31%-904.51%-14660.52%
Net Income Per EBT
100.00%100.00%100.00%100.00%85.66%
EBT Per EBIT
131.62%115.56%119.21%398.50%147.13%
Return on Assets (ROA)
-3523.95%-1702.97%-2214.57%-743.43%-458.97%
Return on Equity (ROE)
15.46%12.58%28.02%183.91%228.08%
Return on Capital Employed (ROCE)
11.62%10.88%23.51%46.15%180.97%
Return on Invested Capital (ROIC)
22.53%20.91%49.20%138.19%-2337.15%
Return on Tangible Assets
-3523.95%-1702.97%-2214.57%-743.43%-458.97%
Earnings Yield
-357.82%-692.73%-370.59%-2487.55%-89.53%
Efficiency Ratios
Receivables Turnover
0.00 0.00 26.19 4.34 0.37
Payables Turnover
0.00 0.00 0.00 0.00 0.43
Inventory Turnover
0.00 0.00 0.00 0.00 -2.46
Fixed Asset Turnover
0.00 0.00 0.00 1.49 0.07
Asset Turnover
0.00 0.00 4.14 0.82 0.04
Working Capital Turnover Ratio
0.00 0.00 -0.05 -0.18 -0.03
Cash Conversion Cycle
0.00 0.00 13.94 84.19 -12.20
Days of Sales Outstanding
0.00 0.00 13.94 84.19 984.10
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 -148.50
Days of Payables Outstanding
0.00 0.00 0.00 0.00 847.80
Operating Cycle
0.00 0.00 13.94 84.19 835.60
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 -1.37
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 -1.37
CapEx Per Share
<0.01 0.00 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-44.91K 0.00 -204.24 0.00 -1.01K
Capital Expenditure Coverage Ratio
-44.91K 0.00 -204.24 0.00 -1.01K
Operating Cash Flow Coverage Ratio
-0.14 -0.14 -0.19 -0.08 -0.95
Operating Cash Flow to Sales Ratio
0.00 0.00 -1.88 -0.27 -56.05
Free Cash Flow Yield
-1294.49%-377.95%-130.89%-75.44%-40.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.28 -0.14 -0.27 -0.04 -1.12
Price-to-Sales (P/S) Ratio
0.00 0.00 1.44 0.36 138.80
Price-to-Book (P/B) Ratio
-0.04 -0.02 -0.08 -0.07 -2.55
Price-to-Free Cash Flow (P/FCF) Ratio
-0.08 -0.26 -0.76 -1.33 -2.47
Price-to-Operating Cash Flow Ratio
-0.61 -0.26 -0.77 -1.33 -2.48
Price-to-Earnings Growth (PEG) Ratio
-0.01 <0.01 <0.01 <0.01 -0.02
Price-to-Fair Value
-0.04 -0.02 -0.08 -0.07 -2.55
Enterprise Value Multiple
-4.19 -4.48 -2.41 -0.38 -1.65
Enterprise Value
1.25M 1.23M 1.46M 1.36M 5.80M
EV to EBITDA
-4.19 -4.48 -2.41 -0.38 -1.65
EV to Sales
0.00 0.00 11.20 3.32 193.58
EV to Free Cash Flow
-6.97 -7.17 -5.93 -12.11 -3.45
EV to Operating Cash Flow
-6.97 -7.17 -5.96 -12.11 -3.45
Tangible Book Value Per Share
>-0.01 -0.03 -0.08 -0.23 -1.33
Shareholders’ Equity Per Share
>-0.01 -0.03 -0.08 -0.23 -1.33
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 -0.01
Revenue Per Share
0.00 0.00 <0.01 0.05 0.02
Net Income Per Share
>-0.01 >-0.01 -0.02 -0.42 -3.04
Tax Burden
1.00 1.00 1.00 1.00 0.86
Interest Burden
1.32 1.15 1.03 1.00 1.17
Research & Development to Revenue
0.00 0.00 1.50 1.05 39.49
SG&A to Revenue
0.00 0.00 3.99 2.18 58.58
Stock-Based Compensation to Revenue
0.00 0.00 1.07 0.44 24.33
Income Quality
0.46 0.55 0.35 0.03 0.45
Currency in USD